EU Panel Blocks Merck KGaA (MKGAF.PK)'s (JOBS) Erbitux in Lung Cancer 11/20/2009
More...
|
OXiGENE (OXGN) Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference 11/17/2009
More...
|
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer 11/4/2009
More...
|
Drug-radiation Combo Eradicates Lung Cancer In Mice, UT Southwestern Medical Center Study 10/30/2009
More...
|
AstraZeneca PLC (AZN) (JOBS) Pulls Submissions for Lung Cancer Drug 10/30/2009
More...
|
Biomoda Prepares for Phase III Clinical Trials 10/28/2009
More...
|
Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study 10/23/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Stops Lung Cancer Study 10/12/2009
More...
|
OXiGENE (OXGN) Announces Data Presentation At 2009 AACR-EORTC-NCI Conference 10/12/2009
More...
|
African American Lung Cancer Patients May Have Different Response To New Cancer-fighting Drugs, University Hospitals Case Medical Center Study 10/9/2009
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 10/5/2009
More...
|
Combination Of PET/CT Tests Can Expedite Diagnosis Of Lung Cancer In A Fast-Track Setting, Netherlands Cancer Institute (NCI) Study 10/2/2009
More...
|
Telik, Inc. (TELK) Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer 10/2/2009
More...
|
Benitec Limited (BLT.AX) and CCIA Collaborate on an RNAi Therapeutic for Lung Cancer 10/1/2009
More...
|
Biomoda Engages Renowned Researcher to Lead Longitudinal Component of Lung Cancer Study 9/30/2009
More...
|
Hormone Replacement Therapy Increases Risk Of Death From Lung Cancer, Harbor Medical Center Study 9/22/2009
More...
|
Lung Cancer Survival Improved By Maintenance Therapy With Pemetrexed, Penn State University Study 9/22/2009
More...
|
Eli Lilly and Company (LLY) (JOBS): Alimta Improved Survival in Lung Cancer 9/21/2009
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 9/15/2009
More...
|
Abbott Laboratories (ABT) (JOBS), Pfizer Inc. (PFE) (JOBS) in Pact for Lung Cancer Screening 8/28/2009
More...
|
Tests Help AstraZeneca PLC (AZN) (JOBS), Roche (RHHBY) (JOBS) Lung Cancer Drugs Reach Right Patients 8/20/2009
More...
|
CytRx Corporation (CYTR)'s Drug Candidate INNO-206 Produces Statistically Significant Tumor Shrinkage in Animal Model of Small Cell Lung Cancer 8/12/2009
More...
|
Celgene (CELG) (JOBS) Cancer Drug May Be Less Harmful to Heart 8/7/2009
More...
|
Biotech Startups Turn To Big Pharma For Survival 8/5/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Release: Results From TH-302 Clinical Trials Presented at International Lung Cancer Meeting 8/5/2009
More...
|
Boehringer Ingelheim Corporation (JOBS) to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations 8/4/2009
More...
|
All-biologic Regimen Efficacious And Well-tolerated In Elderly Lung Cancer Patients, Fox Chase Cancer Center Study Suggests 8/3/2009
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Says Tarceva Extends Lung Cancer Survival 8/3/2009
More...
|
Oncothyreon's Cancer Vaccine Well-Tolerated in Long Use 8/3/2009
More...
|
Cell Therapeutics, Inc. (CTIC): OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer 8/3/2009
More...
|
AstraZeneca PLC (AZN) Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer 7/30/2009
More...
|
Merck KGaA (MKGAF.PK) Falls; EU Rejects Erbitux for Lung Cancer 7/27/2009
More...
|
Ovary Removal May Increase Lung Cancer Risk, University Of Montreal Study 7/22/2009
More...
|
Thalidomide Does Not Improve Survival In Small Cell Lung Cancer, University Hospital in London Study Finds 7/17/2009
More...
|
New Data from OSI Pharmaceuticals, Inc. (OSIP) (JOBS), Genentech, Inc. (Oceanside) (DNA) (JOBS) Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer 7/13/2009
More...
|
Cellceutix Announces Kevetrin(tm) Animal Model Testing Success Against Multi-Drug Resistant Lung Cancer Cell Lines 7/13/2009
More...
|
Eli Lilly and Company (LLY) Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 7/6/2009
More...
|
Europe Approves AstraZeneca PLC (AZN) Lung Cancer Drug 7/1/2009
More...
|
Clarient, Inc. Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer 6/17/2009
More...
|
Vaporized Viral Vector Shows Promise In Anti-cancer Gene Therapy, South Korea's Ministry of Education, Science and Technology Study 6/10/2009
More...
|
Defeating Nicotine's Double Role In Lung Cancer, National Cancer Research Institute in Genoa, Italy Study 6/10/2009
More...
|
Brain Irradiation In Lung Cancer, Medical College of Wisconsin Study 6/8/2009
More...
|
Combined Hormone Therapy Linked to Lung Cancer Mortality, Harbor-UCLA Research and Education Institute (REI) Study 6/1/2009
More...
|
Bayer HealthCare Pharmaceuticals (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 6/1/2009
More...
|
AstraZeneca Pharmaceuticals LP (AZN) Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 6/1/2009
More...
|
Infinity Pharmaceuticals, Inc. Reports Encouraging Clinical Data for IPI-504 at American Society of Clinical Oncology 2009 6/1/2009
More...
|
Boehringer Ingelheim Corporation And DxS Ltd Sign An Agreement For A Companion Diagnostic To Identify EGFR Mutations In Patients With Lung Cancer 5/29/2009
More...
|
Antisoma PLC (ASM.L): Phase II Trial Of ASA404 Published In Lung Cancer 5/21/2009
More...
|
Adult Stem Cells From Bone Marrow Made To Kill Metastatic Lung Cancer Cells In Mice, University College London Study 5/20/2009
More...
|
AstraZeneca PLC (AZN)'s 'Miracle Pill,' Iressa Returns 5/20/2009
More...
|
InterMune, Inc. (ITMN) Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 5/18/2009
More...
|
AccuVein Launches First Portable, Non-Contact Vein Illumination Device 5/18/2009
More...
|
OSI Pharmaceuticals, Inc. (OSIP), Roche Holding AG (RHHBF.PK)'s Tarceva Helps Keep Lung Cancer from Worsening-Study 5/15/2009
More...
|
Clinical Data From Infinity Pharmaceuticals, Inc.'s Hsp90 Chaperone Inhibitor Program to be Presented During American Society of Clinical Oncology Meeting 5/13/2009
More...
|
Exiqon Diagnostics, Inc. Announces KRAS Mutation Analysis for Predicting Therapeutic Response in Colorectal and Non-Small Cell Lung Cancer Patients 5/11/2009
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Says Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 5/5/2009
More...
|
TIP30 Inhibits Lung Cancer Metastasis, Chinese Study Suggests 5/1/2009
More...
|
Cetuximab Prolongs Survival in Non-Small-Cell Lung Cancer, University of Vienna Study 5/1/2009
More...
|
AstraZeneca PLC (AZN) Gets EU Approval For Lung Cancer Drug Iressa 4/24/2009
More...
|
Roche Holding AG (RHHBF.PK) and AstraZeneca PLC (AZN) Face Tussle Over Lung Cancer Pills; Roche To Start New Trial With Tarceva In Lung Cancer 4/24/2009
More...
|
Geron Corporation (GERN) Presentations on Imetelstat (GRN163L) at the American Association for Cancer Research 2009 Annual Meeting 4/22/2009
More...
|
Urine Tests Could Soon Assess Lung Cancer Risk, University of Minnesota Study 4/20/2009
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial 4/20/2009
More...
|
University of Cincinnati Researchers Identify Specific Lung Cancer Susceptibility Gene 4/16/2009
More...
|
High-Dose Radiation Improves Lung Cancer Survival, University of Michigan Study Finds 4/9/2009
More...
|
Encouraging Results Published on Use of TomoTherapy SM in Lung Cancer Treatment 4/9/2009
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 3/25/2009
More...
|
Nereus Pharmaceuticals, Inc. Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer 3/23/2009
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer 3/19/2009
More...
|
TRANSGENE (TRGNY) Confirms Longer Survival For Patients Treated With TG4010 In Its Ongoing Phase IIb Non-Small Cell Lung Cancer Trial 2/17/2009
More...
|
Amgen (AMGN) (JOBS) Says Motesanib Lung Cancer Trial to Resume 2/12/2009
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 2/4/2009
More...
|
OncoGenex Pharmaceuticals Inc. Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer 2/4/2009
More...
|
Genentech, Inc. (DNA) Phase III Study Showed Tarceva in Combination With Avastin as First-Line Maintenance Therapy Improved Progression-Free Survival in Advanced Lung Cancer 2/3/2009
More...
|
Bristol-Myers Squibb Company (BMY) to Refile for Erbitux for Lung Cancer 1/26/2009
More...
|
ImClone Systems Incorporated (IMCL), Bristol-Myers Squibb Company (BMY) Withdraw FDA Application 1/23/2009
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Begins Phase 2 Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer 1/13/2009
More...
|
Test Could Offer Lung Cancer Clue, Cancer Research UK Cambridge Research Institute Study 1/5/2009
More...
|
Experts Identify Gene Variants Linked To Lung Cancer, Fudan University Study 12/22/2008
More...
|
Antisoma PLC (ASM.L) Release: Phase II Trial Showing Improved Survival With ASA404 In Lung Cancer Published In British Journal Of Cancer 12/16/2008
More...
|
Broccoli Compound May Inhibit Lung Cancer From Tobacco Smoke: University of Minnesota Study 12/9/2008
More...
|
Gene Which Protects Against Lung Cancer Identified, University of Nottingham Study 12/3/2008
More...
|
Biomoda, NM Tech Win Legislative Support for Lung Cancer Screening 12/3/2008
More...
|
AstraZeneca PLC (AZN) Lung Cancer Pill May Get Second Chance After Tests 11/21/2008
More...
|
Life Science Weekly inSite (Nov. 14- Nov. 20) 11/21/2008
More...
|
Amgen (AMGN) (JOBS), Takeda (JOBS), and Millennium (JOBS) Suspend Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer; Drug Test Stopped After Deaths 11/20/2008
More...
|
Genetic Trait Could Predict Lung Cancer, British Columbia Cancer Research Study 11/19/2008
More...
|
Broccoli May Lower Lung Cancer Risk In Smokers, Roswell Park Cancer Institute Study 11/19/2008
More...
|
Helix Biopharma (CC:HBP) Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland 11/19/2008
More...
|
Perceptronix to Exhibit at St. Paul's Hospital Annual CME Conference 11/18/2008
More...
|
Lung Cancer Genetics Different in Black Patients, Case Western Reserve University, University of Colorado And Instituto Clinico Humanitas IRCCS Study 11/17/2008
More...
|
Four Drug Combination Helps In Lung Cancer, University of Texas MD Anderson Cancer Center Study 11/14/2008
More...
|
Roche (RHHBY) Release: Avastin(R) Gives An Additional 4 Months Of Life To Patients With One Of The Most Common Types Of Lung Cancer 11/14/2008
More...
|
EntreMed, Inc. (ENMD)'s MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 11/10/2008
More...
|
Tarceva Meets Goal In Phase III Study (SATURN) for Advanced Non-Small Cell Lung Cancer; Roche (RHHBY) (JOBS) to Continue Development Program with OSI Pharmaceuticals, Inc. (OSIP) (JOBS) and Genentech, Inc. (DNA) (JOBS) 11/7/2008
More...
|
Vitamin E May Slash Lung Cancer Risk, University of Texas MD Anderson Cancer Center Study 11/3/2008
More...
|
Infinity Pharmaceuticals, Inc. Announces Expansion of Phase 2 Clinical Study Evaluating IPI-504 in Advanced Non-Small Cell Lung Cancer 10/30/2008
More...
|
Highly Specialized, Minimally Invasive Surgery For Lung Cancer Allows Patient To Go Home Sooner, Fox Chase Cancer Center Researchers Say 10/29/2008
More...
|
Gene Study Turns Up 26 Lung Cancer Genes, International Team Reports 10/23/2008
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial 10/20/2008
More...
|
Roche Holding AG (RHHBF.PK) (JOBS), Genentech, Inc. (DNA) (JOBS) Said Two Drugs Don't Boost Lung Cancer Survival 10/6/2008
More...
|
Genentech, Inc. (DNA) and OSI Pharmaceuticals, Inc. (OSIP) Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer 10/6/2008
More...
|
National Cancer Institute Launches First-Ever Study To Determine If Biomarkers Can Help Guide Treatment For Lung Cancer 10/2/2008
More...
|
FDA Grants Eli Lilly and Company (LLY)'s (JOBS) ALIMTA(R) Third U.S. Approval 9/29/2008
More...
|
Lung Fluid Test May Predict Lung Cancer Risk, University of British Columbia Researchers Report 9/25/2008
More...
|
BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 9/24/2008
More...
|
New Oral Drug Shrinks Lung Cancers Before Surgery, Weil Medical College of Cornell University Researchers Report 9/18/2008
More...
|
Pazopanib Shrinks Lung Cancers Before Surgery, US Researchers Report. 9/17/2008
More...
|
Proteins In Blood Predict Early Lung Cancer, Fred Hutchinson Cancer Research Center and University of Michigan Study; New Cancer-Screening Strategy Uses The Immune System To Signal Early Signs Of Disease 9/16/2008
More...
|
TRANSGENE (TRGNY) Promising Additional Clincial Data in Non Small Cell Cancer Phase 2 Trial 9/15/2008
More...
|
Celgene Corporation (CELG) Release: Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer after First-Line Chemotherapy 9/4/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 9/2/2008
More...
|
ImClone Systems Incorporated (IMCL) Release: ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Did Not Meet Primary Endpoint 8/29/2008
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Recommendations of Data Review Committee for Seliciclib Phase 2b Non-Small Cell Lung Cancer APPRAISE Trial 8/29/2008
More...
|
Human Genome Sciences, Inc. (HGSI) Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 8/22/2008
More...
|
NovaRx Corporation Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 8/21/2008
More...
|
Experimental Chemotherapy Regimen Shows Promise In Treating Advanced Lung Cancer, Kinki University School of Medicine Study 8/13/2008
More...
|
Columbia University Lung Cancer Trial Targets Asbestos-Related Disease 7/22/2008
More...
|
Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 7/22/2008
More...
|
Gene Test for Lung Cancer Aggressiveness Sought in University of Michigan Study 7/21/2008
More...
|
Frost & Sullivan Release: High Unmet Need Spurs European Lung Cancer Therapeutics Market 7/21/2008
More...
|
University of Edinburgh Case Points to Link Between Crohn's Treatment, Cancer 7/17/2008
More...
|
BioNumerik Pharmaceuticals, Inc. Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 7/17/2008
More...
|
Antisoma PLC (ASM.L) Release: ASA404 Programme to Expand with New Pivotal trial in Lung Cancer 7/17/2008
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research 7/14/2008
More...
|
AngioDynamics (ANGO) Release: Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses in Patients with Lung Cancer 7/14/2008
More...
|
New Device Provides Real-Time Assessment of Lung Cancer Status in Massachusetts General Hospital Cancer Center and Harvard Medical School Study 7/3/2008
More...
|
BioTrove, Inc., Gene Express Awarded National Institutes of Health (NIH) Grant to Develop Novel Standardized Genetic Profiling Test 7/1/2008
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 6/30/2008
More...
|
New Clinical Trial at NewYork-Presbyterian Hospital and Columbia-Presbyterian Medical Center for Patients with Asbestos-Associated Lung Cancer 6/27/2008
More...
|
Perceptronix Signs Significant Partnership Agreements for Early Lung Cancer Detection Test, LungSign(TM) 6/25/2008
More...
|
CT Screens for Lung Cancer Not a Cure-All; Harvard Medical School and Mayo Clinic Study Says Patients Should Think Carefully About Test that Has No Direct Evidence of Benefit 6/23/2008
More...
|
University of Navarra Researchers Identify 5 Genes Involved in the Metastasis of Breast Tumors to the Lung 6/23/2008
More...
|
Epigenomics AG Successfully Completes Larger Clinical Study in Early Lung Cancer Detection 6/18/2008
More...
|
Novelos Therapeutics, Inc. and Medical University of South Carolina Peer Reviewed Article Published in Expert Opinion on Investigational Drugs 6/16/2008
More...
|
Benefit Small From Lung Cancer Screening Method, Harvard Medical School and Mayo Clinic Researchers Find 6/11/2008
More...
|
M. D. Anderson Cancer Center and Aureon Laboratories to Evaluate Biomarkers Associated with Non-Small Cell Lung Cancer 6/10/2008
More...
|
Epigenomics AG Successfully Completes Clinical Study in Lung Cancer Diagnosis 6/9/2008
More...
|
Rosetta Genomics Ltd. (ROSG) and M. D. Anderson Cancer Center to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 6/6/2008
More...
|
New Pfizer Inc. (PFE) Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing's Sarcoma 6/3/2008
More...
|
Celgene Corporation (CELG) Release: Data from Studies of Amrubicin in Small-Cell Lung Cancer Presented at the 2008 American Society of Clinical Oncology Meeting Demonstrate Single Agent Anti-Tumor Activity in Western Patient Population 6/3/2008
More...
|
Leeds University Medics Solve An Ancient Riddle -- And Offer New Tool For Diagnosis 6/2/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Positive Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Positive Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
IDM Pharma, Inc. (IDMI) Announces Phase 2 Follow-Up Data Showing IDM-2101 Is Well Tolerated With Positive Survival Trend In Non-Small Cell Lung Cancer Patients - Data Presented At 44th American Society of Clinical Oncology Annual Meeting Further Supports Improvement In Median Survival Vs. External Controls 6/2/2008
More...
|
Oncothyreon Release: Stimuvax Phase 1/2 Survival Data Support Prior Results, Data Presented At 2008 American Society of Clinical Oncology Meeting 6/2/2008
More...
|
Exelixis, Inc. (EXEL) Reports Phase 1 and Phase 2 Data For XL647 at American Society of Clinical Oncology Data Show Activity in First- and Late-Line Treatment of NSCLC 6/2/2008
More...
|
Radiation Therapy Oncology Group Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients 6/2/2008
More...
|
Bayer HealthCare Pharmaceuticals (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) Release: New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
YM BioSciences (YM.TO) Reports Nimotuzumab NSCLC Clinical Data At American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
GlaxoSmithKline (GSK) New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma Gene Expression Profiling of Tumor is Correlated With Clinical Response 5/30/2008
More...
|
Eli Lilly and Company (LLY) Says Phase III Trial of Cancer Drug Alimta Met Primary Endpoint 5/28/2008
More...
|
Ventilator Relieves Lung Cancer Pain In Final Hours; At End Of Life, It May Be Better Than Standard Oxygen Therapy, Istituto Scientifico di Pavia Study 5/21/2008
More...
|
Blood Test for Early Lung Cancer Shows Promise, University of Pennsylvania School of Medicine Study 5/20/2008
More...
|
New Pfizer Inc. (PFE) Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at American Society of Clinical Oncology 5/16/2008
More...
|
Significant Data on ERBITUX(R) (cetuximab) and ImClone Systems Incorporated (IMCL) Pipeline to Be Presented at American Society of Clinical Oncology 2008 Annual Meeting 5/16/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators to Present Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting 5/16/2008
More...
|
External-Beam Radiation Therapy For Localized Prostate Cancer Linked To Bladder, Lung And Colorectal Cancer, Data Presented at American Urological Association Annual Scientific Meeting 5/15/2008
More...
|
Tooth Loss Strongly Linked To Risk Of Esophageal, Head And Neck, And Lung Cancer, Aichi Cancer Center and Nagoya University Study 5/14/2008
More...
|
Oregon Health & Science University (OHSU) Cancer Institute Researchers Have Pinpointed The Protein That Can Lead To Genetic Changes That Cause Lung Cancer 5/14/2008
More...
|
European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics, Inc. (CTIC)'s Lung Cancer Drug 5/5/2008
More...
|
Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer 5/1/2008
More...
|
University of Sheffield Researchers Light Up Lungs To Help Diagnose Disease 4/30/2008
More...
|
Compugen Ltd. (CGEN) Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer 4/29/2008
More...
|
Possible Viral Links to Lung Cancer Risk Uncovered 4/28/2008
More...
|
Mutation Database Helps Personalized Treatment Of Lung Cancer 4/28/2008
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 4/23/2008
More...
|
Genentech, Inc. (DNA)'s AVAiL Phase III Study Fails To Demonstrate Statistically Significant Prolongation Of Overall Survival In Patients With NSCLC 4/21/2008
More...
|
Mouth Swab May One Day Diagnose Lung Cancer, M. D. Anderson Cancer Center Study 4/17/2008
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Presents Data on Lucanthone, a Novel Anticancer Drug, at the Meeting of the American Association for Cancer Research 4/17/2008
More...
|
Infinity Pharmaceuticals, Inc.'s Hedgehog Antagonist Delays Tumor Growth Following Chemotherapy in Preclinical Model of Small Cell Lung Cancer; Data Presented At American Association for Cancer Research 4/16/2008
More...
|
Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented by Infinity Pharmaceuticals, Inc. and MedImmune At American Association for Cancer Research 4/16/2008
More...
|
AVEO Pharmaceuticals, Inc.' Novel Triple VEGF Receptor Inhibitor Shows Tumor Regression in Patients with Advanced Renal Cancer; Clinical Activity and Tolerability in other Solid Tumors including Colon and Lung Cancers 4/15/2008
More...
|
Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer 4/15/2008
More...
|
Mouth Test Could Predict Lung Cancer, University of Texas M. D. Anderson Cancer Center Study Finds 4/14/2008
More...
|
KOSAN Biosciences, Inc. (KOSN) Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 4/14/2008
More...
|
Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer 4/14/2008
More...
|
Alfacell (ACEL)'s ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 4/14/2008
More...
|
Celgene Corporation (CELG) Release: Amrubicin is Designated as an Orphan Medicinal Product by the European Commission for the Treatment of Small Cell Lung Cancer 4/11/2008
More...
|
Higher Chemotherapy Doses No Help in Small-Cell Lung Cancer, University Hospital in Lausanne, Switzerland Sudy 4/10/2008
More...
|
Nektar Therapeutics (NKTR) Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies; Pfizer Inc. (PFE) Warns of Lung Cancer with Inhaled Insulin 4/9/2008
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial 4/9/2008
More...
|
Scientists Identify Lung Cancer Genes 4/3/2008
More...
|
Lung Cancer Investigator "Discloses" Funding of Tobacco Money 4/3/2008
More...
|
Cell Therapeutics, Inc. (CTIC)'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 4/3/2008
More...
|
Boston University School of Medicine Researchers Develop New Method To Test For Lung Cancer 4/2/2008
More...
|
deCODE genetics, Inc. (DCGN) Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer 4/2/2008
More...
|
UCB Group (UCBJF.PK) Release: Phase II Results for CDP791 in Non-small Cell Lung Cancer Support Further Clinical Development 3/31/2008
More...
|
Cigarette Company Paid for Lung Cancer Study 3/26/2008
More...
|
Accuray Inc. Release: CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3/26/2008
More...
|
Celgene (CELG)'s Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer 3/25/2008
More...
|
Rexinoid Developed by NuRx Pharmaceuticals, Inc. (NURX) Shows Promise in Prevention, Treatment of Lung, Breast Cancer 3/25/2008
More...
|
Yale University Scientists Show That A Microrna Can Reduce Lung Cancer Growth 3/21/2008
More...
|
Nereus Pharmaceuticals, Inc. Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 3/20/2008
More...
|
GlobeImmune, Inc. Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients With Non-Small Cell Lung Cancer at Memorial Sloan-Kettering Cancer Center 3/19/2008
More...
|
Johns Hopkins University Study Shows Way To Predict Lung Cancer Recurrence 3/13/2008
More...
|
Novelos Therapeutics, Inc. Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial 3/13/2008
More...
|
ArQule, Inc. (ARQL) Enrolls First Patient in Phase 1/2 Clinical Trial Program of ARQ 197 in Non-Small Cell Lung Cancer 3/13/2008
More...
|
OncoMethylome Sciences S.A. Collaborators Identify Methylation Markers that are Associated with Lung Cancer Recurrence 3/13/2008
More...
|
AstraZeneca PLC (AZN) Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
3/12/2008
More...
|